Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Wallen

Showing results (101-110 of 144) with videos related to

Pageof 15
Sort By:
Journal of Endourology|September 18, 2014
Robotic ureteral reconstruction distal to the ureteropelvic junction: a large single institution clinical series with short-term follow upGordon L Fifer, Mathew C Raynor, Patrick Selph, et al.
Urologic Oncology|July 7, 2009
A multidisciplinary approach to the management of urologic malignancies: does it influence diagnostic and treatment decisions?Raj Kurpad, William Kim, W Kim Rathmell, et al.
BJU International|January 22, 2010
A phase II trial of neoadjuvant erlotinib in patients with muscle-invasive bladder cancer undergoing radical cystectomy: clinical and pathological resultsRaj S Pruthi, Matthew Nielsen, Samuel Heathcote, et al.
The Journal of Urology|June 28, 2016
Integrating Patient Preference into Treatment Decisions for Men with Prostate Cancer at the Point of CareDavid C Johnson, Dana E Mueller, Allison M Deal, et al.
Journal of Laparoendoscopic & Advanced Surgical Techniques. Part A|December 7, 2011
Multi-institutional analysis of robotic radical cystectomy for bladder cancer: perioperative outcomes and complications in 227 patientsAngela B Smith, Mathew Raynor, Christopher L Amling, et al.
Clinical Genitourinary Cancer|May 17, 2022
Testis Cancer Care in North Carolina: Implications for Real-World Evidence and Cancer SurveillanceStephen McMahon, Xi Zhou, Christopher D Baggett, et al.
The Urologic Clinics of North America|September 29, 2023
Linguistic Differences Based on Gender and Race in Urology Application Personal Statements: A Comparison of 2017 and 2023 ApplicationsEmma C Bethel, Asia N Matthew-Onabanjo, Hannah E Kay, et al.
Cancer|July 13, 2012
Who makes the decision regarding the treatment of clinically localized prostate cancer--the patient or physician?: results from a population-based studyLixin Song, Ronald C Chen, Jeannette T Bensen, et al.
Urologic Oncology|December 22, 2009
Neoadjuvant docetaxel/estramustine prior to radical prostatectomy or external beam radiotherapy in high risk localized prostate cancer: a phase II trialWilliam Y Kim, Young E Whang, Raj S Pruthi, et al.
Scientific Reports|March 4, 2017
Associations between Tumor Vascularity, Vascular Endothelial Growth Factor Expression and PET/MRI Radiomic Signatures in Primary Clear-Cell-Renal-Cell-Carcinoma: Proof-of-Concept StudyQingbo Yin, Sheng-Che Hung, Li Wang, et al.
Pageof 15

Showing results (101-110 of 144) with videos related to

Sort By:
Pageof 15
Journal of Endourology|September 18, 2014
Robotic ureteral reconstruction distal to the ureteropelvic junction: a large single institution clinical series with short-term follow upGordon L Fifer, Mathew C Raynor, Patrick Selph, et al.
Urologic Oncology|July 7, 2009
A multidisciplinary approach to the management of urologic malignancies: does it influence diagnostic and treatment decisions?Raj Kurpad, William Kim, W Kim Rathmell, et al.
BJU International|January 22, 2010
A phase II trial of neoadjuvant erlotinib in patients with muscle-invasive bladder cancer undergoing radical cystectomy: clinical and pathological resultsRaj S Pruthi, Matthew Nielsen, Samuel Heathcote, et al.
The Journal of Urology|June 28, 2016
Integrating Patient Preference into Treatment Decisions for Men with Prostate Cancer at the Point of CareDavid C Johnson, Dana E Mueller, Allison M Deal, et al.
Journal of Laparoendoscopic & Advanced Surgical Techniques. Part A|December 7, 2011
Multi-institutional analysis of robotic radical cystectomy for bladder cancer: perioperative outcomes and complications in 227 patientsAngela B Smith, Mathew Raynor, Christopher L Amling, et al.
Clinical Genitourinary Cancer|May 17, 2022
Testis Cancer Care in North Carolina: Implications for Real-World Evidence and Cancer SurveillanceStephen McMahon, Xi Zhou, Christopher D Baggett, et al.
The Urologic Clinics of North America|September 29, 2023
Linguistic Differences Based on Gender and Race in Urology Application Personal Statements: A Comparison of 2017 and 2023 ApplicationsEmma C Bethel, Asia N Matthew-Onabanjo, Hannah E Kay, et al.
Cancer|July 13, 2012
Who makes the decision regarding the treatment of clinically localized prostate cancer--the patient or physician?: results from a population-based studyLixin Song, Ronald C Chen, Jeannette T Bensen, et al.
Urologic Oncology|December 22, 2009
Neoadjuvant docetaxel/estramustine prior to radical prostatectomy or external beam radiotherapy in high risk localized prostate cancer: a phase II trialWilliam Y Kim, Young E Whang, Raj S Pruthi, et al.
Scientific Reports|March 4, 2017
Associations between Tumor Vascularity, Vascular Endothelial Growth Factor Expression and PET/MRI Radiomic Signatures in Primary Clear-Cell-Renal-Cell-Carcinoma: Proof-of-Concept StudyQingbo Yin, Sheng-Che Hung, Li Wang, et al.
Pageof 15